Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: a north american experience

HIGHLIGHTS

• who: David Edward Youssef and collaborators from the Division of Pediatrics, Department of Pediatric Pulmonary Hypertension, Stollery Children`s Hospital, AB, Canada, Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB have published the article: Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience, in the Journal: (JOURNAL) of 26/01/2023

SUMMARY

@@

ACRONYMS

LAY DEFINITIONS

• tadalafil: A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.